ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Condition(s):Solid TumorLast Updated:July 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Solid TumorLast Updated:July 13, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:June 7, 2017Unknown status
Condition(s):Malignant Solid Tumour; Breast Cancer Nos Metastatic Recurrent; NeuropathyLast Updated:February 3, 2021Completed
Condition(s):Solid TumorLast Updated:February 7, 2024Terminated
Condition(s):Solid TumorLast Updated:February 5, 2024Recruiting
Condition(s):Solid TumorLast Updated:March 22, 2024Recruiting
Condition(s):Solid TumorsLast Updated:August 11, 2016Unknown status
Condition(s):Solid Tumors; Brain TumorsLast Updated:January 25, 2022Terminated
Condition(s):Advanced Refractory Solid Tumors; Advanced Triple Negative Breast Cancers; Metastatic Triple Negative Breast CancersLast Updated:April 18, 2023Recruiting
Condition(s):Advanced Solid TumorsLast Updated:June 3, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.